Enveric Biosciences, Inc.
Biotechnology · CAMBRIDGE, MA
BiotechnologySEC Form D
Enveric Biosciences, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 4, 2026, reporting $5,000,002 raised.
Incorporated in Delaware and based in CAMBRIDGE, MA, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Enveric Biosciences, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Joseph E. TuckerExecutive Officer · Director
- Kevin M. CoveneyExecutive Officer
- Michael D. WebbDirector
- George W. KeglerDirector
- Michael SchabackerDirector
- Frank PasqualoneDirector
- Sheila DeWittDirector
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised